Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience
Background The use of covered stent grafts during percutaneous coronary intervention (PCI) is a life saving solution to seal acute iatrogenic vessel rupture. However, the presence of an impenetrable mechanical barrier is also appealing during treatment of friable coronary plaques but the synthetic P...
Saved in:
Published in | Catheterization and cardiovascular interventions Vol. 87; no. 4; pp. 712 - 719 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.03.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
The use of covered stent grafts during percutaneous coronary intervention (PCI) is a life saving solution to seal acute iatrogenic vessel rupture. However, the presence of an impenetrable mechanical barrier is also appealing during treatment of friable coronary plaques but the synthetic PTFE‐membrane that might trigger excessive neointimal proliferation has limited its elective‐use. Pericardium tissue may offer an appealing “natural” alternative. Aim of our study is to report the consecutive 5‐year single center experience with the use of pericardium‐covered stents (PCS) (ITGI‐Medical, Israel) in a variety of emergency and elective applications.
Methods
Nineteen consecutive patients undergoing implantation of PCS at the Royal Brompton in the last 5‐years. Reasons for PCS implantation included treatment of degenerated vein grafts, large coronary aneurysms, and acute iatrogenic vessel rupture.
Results
Angiographic success, defined as the ability of the device to be deployed in the indexed lesion with no contrast extravasation with residual angiographic stenosis <30% and a final thrombolysis in myocardial infarction (TIMI)‐3 flow was achieved in all cases. Procedural success, defined as the achievement of angiographic success without any major adverse cardiovascular event (MACE) was achieved in 94.7% of patients. In‐stent restenosis (ISR) was observed in 26.3% and all patients underwent successful target vessel revascularization with DES (mean time to restenosis 9.0 ± 4.0 months). At a mean follow‐up of 32.5 ± 23.3 months no acute or late stent thrombosis was observed.
Conclusion
PCSs were effective in the treatment of friable embolization‐prone coronary plaques, sealing of acute iatrogenic vessel rupture and exclusion of large aneurysms with no thrombosis but high target lesion revascularization. © 2015 Wiley Periodicals, Inc. |
---|---|
Bibliography: | The Scientific and Technological Research Council of Turkey (TUBITAK) istex:A1FD200D7D322F17641322637CD21CBC7D4DACAD ark:/67375/WNG-2LXB5G8Z-K ArticleID:CCD26131 Conflict of interest: Nothing to report. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1522-1946 1522-726X |
DOI: | 10.1002/ccd.26131 |